skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A nonmagnetic differentiated early planetary body

Authors:
ORCiD logo; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1396590
Grant/Contract Number:
AC02-98CH10886
Resource Type:
Journal Article: Publisher's Accepted Manuscript
Journal Name:
Earth and Planetary Science Letters
Additional Journal Information:
Journal Volume: 468; Journal Issue: C; Related Information: CHORUS Timestamp: 2017-10-04 09:31:33; Journal ID: ISSN 0012-821X
Publisher:
Elsevier
Country of Publication:
Netherlands
Language:
English

Citation Formats

Weiss, Benjamin P., Wang, Huapei, Sharp, Thomas G., Gattacceca, Jérôme, Shuster, David L., Downey, Brynna, Hu, Jinping, Fu, Roger R., Kuan, Aaron T., Suavet, Clément, Irving, Anthony J., Wang, Jun, and Wang, Jiajun. A nonmagnetic differentiated early planetary body. Netherlands: N. p., 2017. Web. doi:10.1016/j.epsl.2017.03.026.
Weiss, Benjamin P., Wang, Huapei, Sharp, Thomas G., Gattacceca, Jérôme, Shuster, David L., Downey, Brynna, Hu, Jinping, Fu, Roger R., Kuan, Aaron T., Suavet, Clément, Irving, Anthony J., Wang, Jun, & Wang, Jiajun. A nonmagnetic differentiated early planetary body. Netherlands. doi:10.1016/j.epsl.2017.03.026.
Weiss, Benjamin P., Wang, Huapei, Sharp, Thomas G., Gattacceca, Jérôme, Shuster, David L., Downey, Brynna, Hu, Jinping, Fu, Roger R., Kuan, Aaron T., Suavet, Clément, Irving, Anthony J., Wang, Jun, and Wang, Jiajun. 2017. "A nonmagnetic differentiated early planetary body". Netherlands. doi:10.1016/j.epsl.2017.03.026.
@article{osti_1396590,
title = {A nonmagnetic differentiated early planetary body},
author = {Weiss, Benjamin P. and Wang, Huapei and Sharp, Thomas G. and Gattacceca, Jérôme and Shuster, David L. and Downey, Brynna and Hu, Jinping and Fu, Roger R. and Kuan, Aaron T. and Suavet, Clément and Irving, Anthony J. and Wang, Jun and Wang, Jiajun},
abstractNote = {},
doi = {10.1016/j.epsl.2017.03.026},
journal = {Earth and Planetary Science Letters},
number = C,
volume = 468,
place = {Netherlands},
year = 2017,
month = 6
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on April 24, 2018
Publisher's Accepted Manuscript

Save / Share:
  • Cartilage is an avascular tissue with only a limited potential to heal and chondrocytes in vitro have poor proliferative capacity. Recently, adipose-derived stromal cells (ASC) have demonstrated a great potential for application to tissue engineering due to their ability to differentiate into cartilage, bone, and fat. In this study, we have utilized a high density three-dimensional (3D) micromass model system of early chondrogenesis with ASC. The material properties of these micromasses showed a significant increase in dynamic and static elastic modulus during the early chondrogenic differentiation process. These data suggest that the 3D micromass culture system represents an in vitromore » model of early chondrogenesis with dynamic cell signaling interactions associated with the mechanical properties of chondrocyte differentiation.« less
  • Short communication.
  • Seventy-two patients affected by differentiated thyroid cancer underwent whole-body scan seven days after the postsurgical thyroablative treatment with /sup 131/I. In 40 patients this scanning did not reveal any area of /sup 131/I uptake outside the residual thyroid parenchyma. During the follow-up period, no signs of functioning tumors were detected in these patients and therefore, there was no need for further therapeutic treatment with radioiodine. From this results it is legitimate to conclude that whole-body scan control can be significantly postponed without diagnostic inaccuracy for those patients whose postthyroablative scans do not reveal diffuse tumor localizations.
  • Short communication.
  • This study is an attempt to unify the evaluation of patients with well-differentiated thyroid cancer after ablative therapy. As such serum thyroglobulin determinations on and off thyroid hormone (T4) therapy and iodine 131 total body scans were examined in 53 patient studies. No metastases were found in patients whose thyroglobulin value was undetectable (less than 1 ng/ml). Values during T4 therapy that were detectable, even as low as 4.2 ng/ml, were occasionally associated with metastases. After T4 withdrawal, thyroglobulin value and scan were obtained. Neither metastasis nor clinically detectable cancer was found in patients whose thyroglobulin value was less thanmore » 10 ng/ml while off T4. Conversely, a value greater than 10 ng/ml was often associated with documented metastases even when the scan was negative. In summary, a thyroglobulin value less than 1 ng/ml during T4 therapy or less than 10 ng/ml off T4 therapy suggests successful therapy and a routine scan could be avoided unless clinically indicated. However, a value greater than 10 ng/ml suggests the presence of metastasis despite a negative scan. Thyroglobulin determination substantially improves the management of these patients.« less